Article

Cornea tolerates prolonged exposure to viscoadaptive

Eugene, OR-Prolonged presence of 2.3% sodium hyaluronate (Healon5, Pfizer) in the eye in association with its use for anterior chamber stabilization following trabeculectomy appears to be well-tolerated by the cornea, according to results of a study undertaken by Richard S. Hoffman, MD, and colleagues at the Oregon Eye Institute, Eugene.

Related Videos
Image credit: Ophthalmology Times; Angiogenesis 2025: Encapsulated cell therapy for MacTel shows long-term efficacy in phase 3 trials
Image credit: Ophthalmology Times; Dean McGee Eye Institute resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster
© 2025 MJH Life Sciences

All rights reserved.